These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14630280)

  • 1. NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2.
    Amirghahari N; Harrison L; Smith M; Rong X; Naumann I; Ampil F; Shi R; Glass J; Nathan CO
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1405-12. PubMed ID: 14630280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
    Raju U; Nakata E; Yang P; Newman RA; Ang KK; Milas L
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):886-94. PubMed ID: 12377342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.
    Li M; Wu X; Xu XC
    Int J Cancer; 2001 Jul; 93(2):218-23. PubMed ID: 11410869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms.
    Zhong H; Willard M; Simons J
    Int J Cancer; 2004 Nov; 112(4):585-95. PubMed ID: 15382039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells.
    Hung WC; Chang HC; Pan MR; Lee TH; Chuang LY
    Mol Pharmacol; 2000 Dec; 58(6):1398-403. PubMed ID: 11093779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431.
    Kanda N; Watanabe S
    J Invest Dermatol; 2002 Nov; 119(5):1080-9. PubMed ID: 12445196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
    Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
    J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway.
    Li M; Wu X; Xu XC
    Clin Cancer Res; 2001 Apr; 7(4):1010-6. PubMed ID: 11309352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
    Liu XH; Yao S; Kirschenbaum A; Levine AC
    Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells.
    Chang HC; Weng CF
    Oncol Rep; 2001; 8(6):1321-5. PubMed ID: 11605058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells.
    Munkarah AR; Genhai Z; Morris R; Baker VV; Deppe G; Diamond MP; Saed GM
    Gynecol Oncol; 2003 Mar; 88(3):429-33. PubMed ID: 12648598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid a radiosensitizes hypoxic EMT-6 tumor cells: role of the NF-kappaB signaling pathway.
    de Ridder M; Verovski VN; Van den Berge DL; Sermeus AB; Monsaert C; Wauters N; Storme GA
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):779-86. PubMed ID: 14529784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production.
    Sumitani K; Kamijo R; Toyoshima T; Nakanishi Y; Takizawa K; Hatori M; Nagumo M
    J Oral Pathol Med; 2001 Jan; 30(1):41-7. PubMed ID: 11140899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclooxygenase-2 with NS-398 and the prevention of radiation-induced transformation, micronuclei formation and clonogenic cell death in C3H 10T1/2 cells.
    Bisht KS; Bradbury CM; Zoberi I; Curry HA; Kaushal A; Roti Roti JL; Gius D
    Int J Radiat Biol; 2003 Nov; 79(11):879-88. PubMed ID: 14698956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
    Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
    Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of chemotherapeutic drug-induced apoptosis by a cyclooxygenase-2 inhibitor in hypopharyngeal carcinoma cells.
    Peng JP; Liu LT; Chang HC; Hung WC
    Cancer Lett; 2003 Nov; 201(2):157-63. PubMed ID: 14607329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepatocellular carcinoma provides a synergistic increase in apoptosis.
    Schmidt CM; Wang Y; Wiesenauer C
    J Gastrointest Surg; 2003 Dec; 7(8):1024-33. PubMed ID: 14675712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.